bremelanotide peptide powder pt141 pt 141

bremelanotide peptide powder pt141 pt 141 Bremelanotide,α-MSH powder, PT-141 powder, PT 141 PowderMolecular formula: C50H68N14O10 
Molar Mass: 1025.2
CAS number: 32780-32-8 
PT-141 Structural Names: cyclo-[Nle4, Asp5, D-Phe7, Lys10]alpha-MSH-(4-10) 
PT-141 is a metabolite of Melanotan 2
Absrtact Bremelanotide (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction, hemorrhagic shock and reperfusion injury. It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limitingischemia. It was originally tested for intranasal administration in treating female sexual dysfunctionbut this application was temporarily discontinued in 2008 after concerns were raised over adverse side effects of increased blood pressure. As of March, 2012, Palatin is conducting a human Phase 2B study using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.

About the Author
freemexy jack

You must logged in for view and post comments.